Get the Stockscreener App
19.81
0.20%
-0.04
After Hours:
19.81
Genmab Adr Stock (GMAB) Latest News
Sea Ltd ADR (NYSE: SE) Jumps 4.64%, Turning Investors Away - Stocks Register
Does Genmab ADR (NASDAQ: GMAB) Still Look Hot This Week? - Stocks Register
Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - MSN
GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN
Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance
Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
10 Biggest Biotechnology Companies - Investopedia
Weekly Upgrades and Downgrades - InvestorPlace
Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance
Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance
GMAB or INCY: Which Is the Better Value Stock Right Now? - Yahoo Finance
Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance
Market Resilience: Genmab ADR (GMAB) Finishes Weak at 24.14, Down -5.44 - The Dwinnex
GANDHIM.APPL Share Price Today Up 13% - Equitymaster
Glenmark Pharma Share Price Today Down 3% - Equitymaster
Post-Trade Analysis: Genmab ADR (GMAB) Climbs 1.55, Closing at 26.90 - The Dwinnex
Market Recap: Genmab ADR (GMAB)’s Negative Momentum, Closing at 27.41 - The Dwinnex
All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy - MSN
BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls - Yahoo Finance
Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet - Yahoo Finance
GMAB vs. CSLLY: Which Stock Is the Better Value Option? - Yahoo Finance
Wall Street Analysts Believe Genmab (GMAB) Could Rally 52.33%: Here's is How to Trade - Yahoo Finance Australia
RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com
GMAB vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance
GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com
Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily
GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com
New Strong Buy Stocks for January 17th - Yahoo Finance
GMAB: 3 Biotech Stocks to Boost Portfolios - StockNews.com
GMAB: 3 Biotech Stocks to Watch in November - StockNews.com
Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch
GMAB: 2 Explosive Biotech Stocks to Own - StockNews.com
Stocks Generating Improved Relative Strength: Genmab ADR - Investor's Business Daily
Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily
Moderna Stock Getting Closer To Key Technical Benchmark - Inkl
GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada
Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Horizon Therapeutics Is A Stock With Rising Relative Strength - Investor's Business Daily
Genmab's chief development officer sells shares in US - MedWatch
Stocks To Watch: Genmab Sees Relative Strength Rating Jump To 82 - Investor's Business Daily
Zealand Pharma to delist in US - MedWatch
Should You Buy Genmab (GMAB) Ahead of Earnings? - Yahoo Finance
Inside Genmab's blockbuster IPO - IR Magazine
Pipeline of Proprietary Antibodies - flow – Deutsche Bank
Emergent BioSolutions Sees Its Composite Rating Rise To 97 - Investor's Business Daily
Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drug - Yahoo Finance
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga
Genmab's offering and listing in the USA - Bech-Bruun
Genmab AS (GMAB) Stock Price, Trades & News - GuruFocus.com
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):